Clinical implications of lung neuroendocrine neoplasm classification.
Jasna MetovicMarco BarellaSergio HarariLinda PattiniAdriana AlbiniAngelica SonzogniGiulia VeronesiMauro PapottiGiuseppe PelosiPublished in: Expert review of anticancer therapy (2020)
We provide practical insights to account for intratumor heterogeneity, practice the choice of immunohistochemistry markers, and emphasize once again the added value of immuno-oncology in the setting of personalized medicine of lung NENs.